DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Marea Therapeutics, Inc.
Marea Therapeutics, Inc.
Stage unknownSan Francisco, CABiotechnology
Facts
Financing history
1 rounds
- Jun 11, 2024Form D equity offering · $65.4M (form d sold) · 10 investorsFact SEC EDGAR Form D data sets (quarterly) · “Marea Therapeutics, Inc. filed Form D: $65,418,629 sold of $160,418,629, Biotechnology”
Investors on record
1 edges
- Venbio Partners LLC board only, Aaron Royston (strongly supported) Inference sec.gov
People
5 officers, 7 directors
- Caitlin Murray Executive Officer sec.gov
- Christine Garrett Executive Officer sec.gov
- Ethan Weiss Executive Officer sec.gov
- Josh Lehrer Executive Officer/Director sec.gov
- Mark Joing Executive Officer sec.gov
- Jeff Tong Director Fact
- Aaron Royston Director Inference
- Jung Choi Director Fact
- Maha Katabi Director Fact
- TED Love Director Fact
- Antoine Boulanger Director Fact
- Chris Garabedian Director Fact
Timeline
1
- Jun 24, 2024Marea Therapeutics, Inc. filed Form D: $65,418,629 sold of $160,418,629, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company
- Entity type: Corporation Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $65.4M Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $160M Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-06-11 Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 10 Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 135 MISSISSIPPI STREET, SAN FRANCISCO, CA, 94107 Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2021 Jun 24, 2024 Fact SEC EDGAR Form D data sets (quarterly)